PEPTIMER

Welcome to the Brand page for “PEPTIMER”, which is offered here for Peptide-based immune system response modifiers in prescription pharmaceutical compositions for the modulation of immune or autoimmune responses in the prophylaxis or treatment of conditions in the nature of insulin dependent, juvenile-onset diabetes, multiple sclerosis, pemphigus vulgaris, grave's disease, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, hashimoto's thyroiditis, asthma, pathogenic infections, cancer, and allogeneic tissue graft rejection;.

Its status is currently believed to be active. Its class is unavailable. “PEPTIMER” is believed to be currently owned by “Peptimmune, Inc.”


Owner:
PEPTIMMUNE, INC.
Owner Details
Description:
Peptide-based immune system response modifiers in prescription pharmaceutical compositions for the modulation of immune or autoimmune responses in the prophylaxis or treatment of conditions in the nature of insulin dependent, juvenile-onset diabetes, multiple sclerosis, pemphigus vulgaris, Grave's disease, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, asthma, pathogenic infections, cancer, and allogeneic tissue graft rejection;
Categories: PEPTIDE BASED IMMUNE SYSTEM RESPONSE MODIFIERS